Recent Quarter Total Invested
$734.90 M
Recent Quarter Institutional Ownership Percentage
92.51%
Total Invested of Last Quarter
$548.11 M
Ownership Percentage of Last Quarter
91.08%
Castle Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.12 M | $88.99 M | 100.00% | 11.21% |
| WASATCH ADVISORS LP | 11/14/2024 | 1.83 M | $52.08 M | -21.56% | 6.56% |
| PRINCIPAL FINANCIAL GROUP INC | 10/31/2024 | 1.54 M | $43.88 M | 2.70% | 5.53% |
| BELLEVUE GROUP AG | 11/14/2024 | 1.26 M | $35.99 M | 3.69% | 4.53% |
| PORTOLAN CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.26 M | $35.81 M | 3.69% | 4.51% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 864,821 | $24.66 M | 6.78% | 3.11% |
| STATE STREET CORP | 11/14/2024 | 680,001 | $19.39 M | 9.84% | 2.44% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 662,332 | $18.89 M | -22.41% | 2.38% |
| CITADEL ADVISORS LLC | 11/14/2024 | 633,016 | $18.05 M | -8.71% | 2.27% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 624,683 | $17.82 M | 1.13% | 2.24% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 542,593 | $15.47 M | 89.38% | 1.95% |
| PALISADE CAPITAL MANAGEMENT, LP | 11/14/2024 | 502,317 | $14.33 M | -6.63% | 1.80% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 499,192 | $14.24 M | 828.26% | 1.79% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 496,521 | $14.16 M | -4.14% | 1.78% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 489,562 | $13.96 M | 62.38% | 1.76% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 425,220 | $12.13 M | -59.84% | 1.53% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 10/31/2024 | 407,238 | $11.61 M | -24.98% | 1.46% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 401,238 | $11.44 M | 43.05% | 1.44% |
| MORGAN STANLEY | 11/14/2024 | 396,919 | $11.32 M | 59.16% | 1.43% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 349,229 | $9.96 M | 18.78% | 1.25% |
| BRAIDWELL LP | 11/14/2024 | 331,986 | $9.47 M | -20.21% | 1.19% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 296,071 | $8.44 M | 6.54% | 1.06% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 274,761 | $7.84 M | 16.75% | 0.99% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 242,800 | $6.92 M | 11.82% | 0.87% |
| NEXT CENTURY GROWTH INVESTORS LLC | 11/14/2024 | 234,091 | $6.68 M | -1.16% | 0.84% |
| MARSHALL WACE, LLP | 11/14/2024 | 220,797 | $6.30 M | 4.13% | 0.79% |
| INTRINSIC EDGE CAPITAL MANAGEMENT LLC | 11/08/2024 | 212,711 | $6.07 M | -16.39% | 0.76% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 11/14/2024 | 201,921 | $5.76 M | 100.00% | 0.73% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 201,747 | $5.75 M | 153.41% | 0.72% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 190,570 | $5.44 M | 106.08% | 0.68% |
| NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 183,931 | $5.25 M | -2.02% | 0.66% |
| ADVISORS CAPITAL MANAGEMENT, LLC | 11/14/2024 | 167,927 | $4.79 M | 18.01% | 0.60% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 165,458 | $4.72 M | 147.37% | 0.59% |
| SHELTON CAPITAL MANAGEMENT | 11/14/2024 | 164,008 | $4.68 M | 100.00% | 0.59% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 159,624 | $4.55 M | 274.26% | 0.57% |
| LISANTI CAPITAL GROWTH, LLC | 11/04/2024 | 154,710 | $4.41 M | 60.24% | 0.56% |
| HARBOR CAPITAL ADVISORS, INC. | 10/29/2024 | 153,907 | $4.39 M | 10.96% | 0.55% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 140,537 | $4.01 M | 303.53% | 0.50% |
| ALGERT GLOBAL LLC | 11/12/2024 | 134,321 | $3.83 M | 0.45% | 0.48% |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 11/15/2024 | 88,908 | $2.54 M | 0.00% | 0.32% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 76,578 | $2.18 M | -20.80% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 72,900 | $2.08 M | 118.26% | 0.26% |
| ORION PORTFOLIO SOLUTIONS, LLC | 11/15/2024 | 72,405 | $2.06 M | 16.63% | 0.26% |
| ALLIANZ ASSET MANAGEMENT GMBH | 11/13/2024 | 70,553 | $2.01 M | 100.00% | 0.25% |
| JPMORGAN CHASE & CO | 11/08/2024 | 69,409 | $1.98 M | 165.24% | 0.25% |
| FRANKLIN RESOURCES INC | 11/12/2024 | 69,382 | $2.38 M | 87.33% | 0.25% |
| ENVESTNET ASSET MANAGEMENT INC | 11/07/2024 | 67,386 | $1.92 M | 43.08% | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 11/14/2024 | 62,868 | $1.79 M | -59.01% | 0.23% |
| BIRCHVIEW CAPITAL, LP | 11/14/2024 | 58,000 | $1.65 M | 70.59% | 0.21% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 57,845 | $1.65 M | 100.00% | 0.21% |
Castle Biosciences, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CSTL shares?
During the previous two years, 218 institutional investors and hedge funds held shares of Castle Biosciences, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 3.12 M
WASATCH ADVISORS LP: 1.83 M
PRINCIPAL FINANCIAL GROUP INC: 1.54 M
Bellevue Group AG: 1.26 M
Portolan Capital Management, LLC: 1.26 M
DIMENSIONAL FUND ADVISORS LP: 864,821
-
What percentage of Castle Biosciences, Inc. stock is owned by institutional investors?
92.51% of Castle Biosciences, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CSTL ?
Institutional investors have bought a total of 27.33 M shares in the last 24 months. This purchase volume represents approximately $788.21 M in transactions.